Literature DB >> 6489521

Transfer of ferritin-bound iron to adriamycin.

E J Demant.   

Abstract

Interactions of adriamycin with ferritin-bound iron have been investigated. It is demonstrated (i) that adriamycin stimulates an iron-dependent lipid peroxidation in submitochondrial particles in the presence of ferritin, and (ii) that incubation of adriamycin with ferritin results in a slow transfer of iron to adriamycin with formation of an adriamycin-iron complex. The results are discussed in relation to the possible role for intracellular iron in adriamycin toxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489521     DOI: 10.1016/0014-5793(84)80919-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  DNA damage induced by doxorubicin, 4'-epidoxorubicin and their copper(II) complexes.

Authors:  D Cova; M Sassano; E Monti; F Piccinini
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Stability of adriamycin-induced DNA adducts and interstrand crosslinks.

Authors:  A van Rosmalen; C Cullinane; S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

3.  Biochemical changes induced by intravitreally-injected doxorubicin in the iris-ciliary body and lens of the rabbit eye.

Authors:  A C Phylactos; W G Unger
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

Review 4.  Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics.

Authors:  James H Doroshow
Journal:  Curr Pharm Biotechnol       Date:  2012-08       Impact factor: 2.837

Review 5.  Oxidative stress in chemical toxicity.

Authors:  H Kappus
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

6.  Essential fatty acids alter the activity of manganese-superoxide dismutase in rat heart.

Authors:  A C Phylactos; L S Harbige; M A Crawford
Journal:  Lipids       Date:  1994-02       Impact factor: 1.880

7.  The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.

Authors:  B B Hasinoff; S V Kala
Journal:  Agents Actions       Date:  1993-05

8.  Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex.

Authors:  B B Hasinoff
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

9.  Cardioprotection with ICRF-187 (Cardioxane) in patients with advanced breast cancer having cardiac risk factors for doxorubicin cardiotoxicity, treated with the FDC regimen.

Authors:  S Jelić; S Radulović; Z Nesković-Konstantinović; M Kreacić; Z Ristović; S Bosnjak; N Milanović; L Vuletić
Journal:  Support Care Cancer       Date:  1995-05       Impact factor: 3.603

10.  Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids.

Authors:  B C Hüsken; J de Jong; B Beekman; R C Onderwater; W J van der Vijgh; A Bast
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.